News | Teleradiology | October 20, 2021

Researchers from Memorial Sloan Kettering Cancer Center (MSK) reviewed patient surveys before and during the COVID-19 pandemic, found higher percentage preferred telemedicine and that general patient satisfaction scores were equally high for both video conferencing and office visits

New research in the October 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network assessed patient satisfaction and preferences for telemedicine, finding 45% of people with cancer preferred telemedicine, while 34% preferred office visits, and 21% had no preference.

Getty Images

October 20, 2021 — New research in the October 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network assessed patient satisfaction and preferences for telemedicine, finding 45% of people with cancer preferred telemedicine, while 34% preferred office visits, and 21% had no preference.

The researchers reviewed survey responses from 1,077 radiation oncology patients across NCCN Member Institution Memorial Sloan Kettering Cancer Center (MSK)’s main campus and six regional locations across New York and New Jersey. The questionnaires were based on office and telemedicine visits between December 2019 and June 2020. In terms of patient satisfaction, most reported either no difference or improvement with telemedicine overall (91%) compared to office visits, with similar results for their confidence in their physician (90%), understanding their treatment plans (88%), and confidence their cancer will be treated appropriately (87%).

“These findings provide some evidence that there is a role for telemedicine beyond the COVID-19 pandemic and that it can be a particularly useful tool for certain patients—especially those who may have challenges coming on-site for an appointment,” said co-lead author Narek Shaverdian, M.D., MSK Department of Radiation Oncology. “Giving patients flexibility and options by being able to see them both in-person and through telemedicine can improve access to care.”

Notably, the survey results found that two-thirds of respondents considered telemedicine to be a superior option when it came to treatment-related costs, such as travel and lost wages.

“An individual visit to the physician’s office can be costly—including transportation, parking, and time off from other activities,” said co-lead author Erin F. Gillespie, M.D., MSK Department of Radiation Oncology. “Telemedicine takes away most of this cost and inconvenience, and could therefore reduce the overall burden of engaging with the healthcare system. Also, the ability for family and friends to join the conversation from any location can be game-changing.”

The researchers found patient responses varied significantly between video conferencing versus audio. Patients who had telephone-only appointments were more likely to say they thought they would benefit more from an in-person visit.

“Telemedicine can be a resource to increase access to care, but only if patients have and can use these video capabilities,” said  Shaverdian. “There is so much that you learn just by seeing a patient and using visual cues to guide a discussion. A voice-only encounter with a patient you’ve never met before is challenging.”

“Digital tools like telemedicine have the unfortunate potential consequence of paradoxically increasing disparities in access to care,” noted Gillespie. “But the counter to that is there will be some disadvantaged patients that would not have accessed the system at all, either due to technologic barriers or travel time, and now can connect at least by phone, which is an important and positive change.”

“Telehealth has transformed cancer care throughout the United States, with widespread adoption in an incredibly short timeframe in response to the pandemic,” commented Anne Chiang, M.D., Ph.D., Associate Professor of Medicine, Yale Cancer Center/Smilow Cancer Hospital, a member of the NCCN Policy Advisory Group who was not involved in this research. “This is such an important study as it collects and analyzes data from more than 1,000 radiation oncology patients to compare telehealth and in-person office visits. From the viewpoint of the patient, there were no significant differences across multiple domains of patient satisfaction between types of visits. In fact, some patients preferred telehealth visits and noted that telemedicine could reduce travel costs and time. The bottom line is that this study supports the use of telehealth as a permanent transformation of the healthcare landscape.”

The NCCN EHR Oncology Advisory Group also recently published research in the Journal of Oncology Practice sharing the oncologist perspective on telemedicine. They surveyed 1,038 providers from 26 institutions in the summer of 2020 and found an estimated 46% of post-pandemic visits could be virtual.

For more information:

Related Telehealth Content:

TSIM: A Model for Telehealth

Is Telehealth the New Normal?

Just Consider the Possibilities

4 Emerging Trends and Technologies in Teleradiology

Related Content

News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
Videos | RSNA

At RSNA23, Imaging Technology News (ITN) spoke with Bhvita Jani, principal analyst at Signify Research, about ...

Time February 07, 2024
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
News | Treatment Planning

February 2, 2024 — RaySearch Laboratories announced that the number of radiotherapy centers that have chosen RayStation ...

Time February 02, 2024
Feature | Radiology Business | By Melinda Taschetta-Millane

It's a new year, and as another month comes to a close, ITN takes a look at the Top 10 most-read pieces of content from ...

Time February 01, 2024
Feature | Radiology Business | By Melinda Taschetta-Millane

Did you know that Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from ...

Time January 29, 2024
News | Digital Pathology

January 26, 2024 — New research funded by the National Institute for Health and Care Research (NIHR) has led to the UK ...

Time January 26, 2024
News | Proton Therapy

January 26, 2024 — P-Cure continues its quest to successfully usher in a new era of clinical treatment with proton ...

Time January 26, 2024
News | Artificial Intelligence

January 24, 2024 — Nonfunctional pancreatic neuroendocrine tumors, while rare, are primarily treated through surgery ...

Time January 24, 2024
Subscribe Now